Prostate Cancer Information Center
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Prostate Cancer Information Center has current, evidence-based information for you. Get the facts about prostate cancer prevention, early detection, treatment, and survivorship, and stay up to date with ongoing prostate cancer research that could impact your treatment decisions through our daily cancer news.
You are not alone—The CancerConnect Prostate Cancer Community is the leading Social Media Application for Prostate Cancer patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.
High dose stereotactic body radiotherapy (SBRT) for men newly-diagnosed with low-... Pass it On: It’s National Prostate Cancer Awareness Month
Prostate cancer is the most common type of cancer in men other than skin cancer,... Midlife PSA Levels Correlate to Risk of Future Lethal Prostate Cancer
A baseline prostate-specific antigen (PSA) level among men at midlife appears to...
Erectile dysfunction is an issue for a large number of men. Eric J. Margolis, MD,... Understanding Osteonecrosis of the Jaw
Cancer and its treatment can come with a variety of complications, some more serious... Understanding Proton Therapy
As cancer treatment evolves, it continues to go high-tech. Radiation is no longer...
Prostate Cancer Management
Rudy Giuliani’s wife discusses her partnership with her husband during his prostate... Moving Bodies, Changing Lives
Moving On Aerobics helps women regain joy of movement and physical fitness after... Where Kids Can Be Kids… And Cancer Takes a Back Seat
Cancer camps for kids provide fun and camaraderie for children facing down a cancer...
Prostate Cancer Clinical Trials
HRRC03-376 – Investigation of Protein Biomarkers of Prostate Cancer
90203 – A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
AT-101-CS-205 – A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Study Comparing AT-101 in Combination with Docetaxel and Prednisone versus Docetaxel and Prednisone in Men with chemotherapy-Naïve Metastatic HRPC.